Healthcare and Medical

home | healthcare and medical | company profile

£265.00
Report Delivery: Via Email
Change Currency EuroUSDGBP

GTC Biotherapeutics Inc - Premium Company Profile (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 01 Jan 2008
  • Report Title: GTC Biotherapeutics Inc - Premium Company Profile
  • Table of Contents: View Table of Contents
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 48
Introduction

GTC Biotherapeutics is engaged in the development, production and commercialization of therapeutic proteins expressed and purified from the milk of transgenic animals such as goats and cattle. ATryn, the company's major product, is a recombinant human antithrombin produced in the milk of transgenic goats.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    GTC develops, produces, and commercializes therapeutic proteins through transgenic animal technology. In addition to ATryn, GTC is working with LFB Biotechnologies to develop recombinant forms of human factor VIIa and a CD20 monoclonal antibody.

    Total revenues of the company witnessed decline at a CAGR of 11% during 2002-2006, from $10 million to $6 million. It derives its revenues from collaborative agreements which include non-refundable license fees, funding of research and development, payments based upon the achievement of certain milestones and royalties.

    Between 2006 and 2010, the company's revenues are forecasted to increase at a CAGR of 22% from $6 million to $13 million. There will be an absolute growth of +$7 million in the company's total revenues by 2010. The company is expected to receive all of its revenues through collaborative agreements with its partners.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • £265.00   Share Report
     
         

    Browse over 450,000 market research reports, company profile reports and company financials. Search by industry sector, or simply search market research reports or company profiles by keyword. Companiesandmarkets.com contains one of the world's largest collections of market research reports and company profiles from leading global market research report publishers and analysts. Global brands rely on companiesandmarkets.com for their strategic market research needs.

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card, Credit Card, or by Invoice.

    Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.

    Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.

    Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    Worldpay Logo
    Chancy Currency EUR USD GBP
    Customer Area
    English Italian Spanish French German Russian Chinese Arabic